Skip to market wire
Back to Market返回行情

LMMY Exousia Bio, Inc.

OTCConsumer Defensive
$0.1650+2.17%ClosedMarket Cap: $1.3M

As of 2026-08-21 16:00

Why LMMY matters now

Exousia Bio, Inc. (LMMY) is a US stock in Consumer Defensive. The latest InvestLog snapshot shows $0.17 with +2.17% on the session and $1.3M in market capitalization.

Company Info

Sector

Consumer Defensive

Industry

Education & Training Services

Country

US

Exchange

OTC

Beta

Exousia Bio, Inc. is a biotechnology company that designs, develops, and manufactures mammalian- and plant-derived exosomes using proprietary technologies for nucleic acid loading and targeted delivery to tissues and cells. The company's platform enables the custom production of exosomes with enhanced genetic functionality that can selectively target specific cells to address diseases. The company was formerly known as LAMY and changed its name to Exousia Bio, Inc. in January 2026.